Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Leatt (LEAT) Research & Development (2018 - 2025)

Leatt (LEAT) has disclosed Research & Development for 8 consecutive years, with $688223.0 as the latest value for Q3 2025.

  • On a quarterly basis, Research & Development rose 11.0% to $688223.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $2.7 million, a 7.44% increase, with the full-year FY2024 number at $2.5 million, changed 0.11% from a year prior.
  • Research & Development was $688223.0 for Q3 2025 at Leatt, up from $616795.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $719291.0 in Q4 2024 to a low of $405105.0 in Q1 2021.
  • A 5-year average of $580356.9 and a median of $610589.0 in 2023 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: skyrocketed 32.25% in 2021, then decreased 4.99% in 2024.
  • Leatt's Research & Development stood at $507663.0 in 2021, then soared by 30.77% to $663849.0 in 2022, then grew by 5.14% to $698002.0 in 2023, then grew by 3.05% to $719291.0 in 2024, then dropped by 4.32% to $688223.0 in 2025.
  • Per Business Quant, the three most recent readings for LEAT's Research & Development are $688223.0 (Q3 2025), $616795.0 (Q2 2025), and $664490.0 (Q1 2025).